Study on neutralization of low molecular weight heparin (LHG) by protamine sulfate and its neutralization characteristics.
The neutralizing effects of protamine sulfate (PS) on anticoagulant activities of low molecular weight heparin (LHG) and conventional sodium heparin (Heparin) were investigated. The in vitro anti-factor Xa and APTT-prolonging activities of Heparin were almost completely neutralized by PS, whereas the activities of LHG remained partially intact in the presence of PS. Crossed immunoelectrophoresis of antithrombin III (AT III) and affinity chromatography of LHG- and Heparin-cellulose showed that AT III was substantially less dissociated from its binding to LHG than to Heparin in the presence of PS. As in vitro, the in vivo anticoagulant activities of Heparin administered i.v. to rabbits were almost completely neutralized by PS, while the anti-factor Xa and APTT-prolonging activities of LHG remained partially intact in the presence of PS. The thrombin time-prolonging activity of LHG, however, was completely inhibited by PS. Since the bleeding effect of Heparin or LHG is considered mainly due to its anti-thrombin activity, PS may be used as an agent to neutralize LHG, as in the case of Heparin, when bleeding happens to occur during LHG treatment.
Sugiyama
T
T
Research Department, Shimizu Pharmaceutical Co., Ltd., Shizuoka, Japan.
Itoh
M
M
Ohtawa
M
M
Natsuga
T
T
D000818:Animals; D000990:Antithrombin III / Q000737:chemistry; D002846:Chromatography, Affinity; D006493:Heparin / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D007123:Immunoelectrophoresis, Two-Dimensional; D008297:Male; D011479:Protamines / Q000494:pharmacology*; D011817:Rabbits
D006495:Heparin, Low-Molecular-Weight; D011479:Protamines; D000990:Antithrombin III; D006493:Heparin